The bio-materials company Seprify has announced the transition of its cellulose platform from pilot validation into procurement-ready industrial supply, enabling manufacturers to move from trials into repeatable sourcing and longer-term commercial agreements.
In a statement, the company said that the move was in response to "growing demand for scalable, bio-based alternatives to high-emission incumbent materials such as titanium dioxide."
The company is supported by Inter IKEA Group, which invested during a €13.4m Series A round alongside investors Una Terra Early Growth Fund, Zürcher Kantonalbank (ZKB), Cambridge Enterprise Ventures, Kickfund and other circular-economy-aligned investors.
Seprify's cellulose platform has reached Technology Readiness Levels (TRL) 7-9 through collaboration with industry partners and is now advancing through supplier qualification, early commercial contracts and procurement discussions in cosmetics, food, pet food and coatings.
The platform combines extensive expertise and strong intellectual property, featuring flagship products such as SilvaLuma, a cellulose-based SPF booster for cosmetics and SilvaAlba, a food-grade whitening alternative to titanium dioxide.
The company said it is currently working with "more than 100 customer organisations," from active evaluations to early commercial supply agreements.
Why this matters
A bio-based alternative to titanium dioxide offers significant benefits to the food and beverage industry by helping manufacturers replace synthetic whitening agents with ingredients derived from renewable biological sources.
This is a small extract of the full article which is available
ONLY to premium content subscribers.
Click below to get premium content on Nutraceutical Business Review.
Not yet a Subscriber?